Endometrial Carcinoma

About
Mappings

OncoTree: Endometrial Carcinoma (oncotree:UCEC)

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) dMMR Endometrial Carcinoma Carboplatin, Durvalumab, Paclitaxel
Sensitivity (+) pMMR Endometrial Carcinoma Carboplatin, Durvalumab, Olaparib, Paclitaxel
Sensitivity (+) dMMR Endometrial Carcinoma Carboplatin, Dostarlimab, Paclitaxel
Sensitivity (+) MSI-H Endometrial Carcinoma Carboplatin, Dostarlimab, Paclitaxel
Sensitivity (+) dMMR Endometrial Carcinoma Dostarlimab
Sensitivity (+) MSI-H Endometrial Carcinoma Dostarlimab
Sensitivity (+) MSI-H Endometrial Carcinoma Pembrolizumab
Sensitivity (+) dMMR Endometrial Carcinoma Pembrolizumab
Sensitivity (+) pMMR Endometrial Carcinoma Durvalumab, Olaparib
Sensitivity (+) dMMR Endometrial Carcinoma Carboplatin, Dostarlimab, Paclitaxel
Sensitivity (+) MSI-H Endometrial Carcinoma Carboplatin, Dostarlimab, Paclitaxel
Sensitivity (+) dMMR Endometrial Carcinoma Dostarlimab
Sensitivity (+) dMMR Endometrial Carcinoma Carboplatin, Durvalumab, Paclitaxel
Sensitivity (+) MSI-L Endometrial Carcinoma Lenvatinib, Pembrolizumab
Sensitivity (+) pMMR Endometrial Carcinoma Pembrolizumab
Sensitivity (+) MSI-H Endometrial Carcinoma Pembrolizumab